A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes Post author:Annie Holland Post published:February 18, 2025 Post category:News Feed Post comments:0 Comments New research shows sotagliflozin is the only drug in its class to demonstrate these results. You Might Also Like Music makes us move even when we don’t like it February 12, 2025 Potential new therapeutic targets for Huntington’s disease January 8, 2025 Scientists invent new drug candidates to treat antibiotic-resistant bacteria February 24, 2025 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.